racemetirosine has been researched along with Retinal Degeneration in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vugler, AA | 1 |
| Redgrave, P | 1 |
| Hewson-Stoate, NJ | 1 |
| Greenwood, J | 1 |
| Coffey, PJ | 1 |
1 other study available for racemetirosine and Retinal Degeneration
| Article | Year |
|---|---|
Constant illumination causes spatially discrete dopamine depletion in the normal and degenerate retina.
Topics: alpha-Methyltyrosine; Animals; Dopamine; Female; Immunohistochemistry; Light; Male; Photoreceptor Ce | 2007 |